“Global Cancer Immunotherapies Market: Global Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast, 2021-2026” provides a deep and thorough evaluation of the global Cancer Immunotherapies market. Cancer immunotherapies, also known as immuno-oncology, are cancer treatments that stimulate the immune system to detect and eliminate cancer cells. They comprise several treatment therapies, such as immune checkpoint inhibitors, T-cell transfer therapy, monoclonal antibodies, treatment vaccines, and immune system modulators, that can be administered orally, intravenously, topically, or intravesically.
The global market is driven by the rising prevalence of cancer, which has fueled the demand for efficient cancer treatments, including immunotherapies. Unlike traditional non-targeted therapies, such as chemotherapy and radiotherapies, immunotherapies are associated with minimal risks of side effects, due to which they are increasingly preferred by both patients and healthcare professionals. Furthermore, extensive research and development (R&D) activities in the field of oncology are expected to boost the market growth.
Key Segments and Highlights of the Global Cancer Immunotherapies Market
The report is a result of exhaustive primary and secondary research undertaken by analysts having years of experience in the Cancer Immunotherapies industry. All the qualitative and quantitative aspects of the industry have been covered and the collected data has been analysed and presented in the form of easily comprehensible charts, graphs and tables.
1 Introduction
1.1 Research Objectives
1.2 Stakeholders
1.3 Scope of the Report
1.4 Assumptions and Limitations
2. Research Methodology
2.1. Data Collection
2.1.1 Primary Sources
2.1.2 Secondary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Data Validation
3. Executive Summary
4. Global Cancer Immunotherapies Market
4.1 Industry Overview
4.2 Key Industry Developments
4.3 Market Trends
4.3.1 Key Market Indicators
4.3.2 Historical Market Trends
4.3.3 Market Forecast
4.4 Price Analysis
4.4.1 Key Price Indicators
4.4.2 Pricing Structure
4.4.3 Historical Price Trends
4.4.4 Price Forecast
4.5 Market Breakup By Region
4.6 Market Breakup By Type
5. Global Cancer Immunotherapies Market: Value Chain Analysis
5.1 Overview
5.2 Research and Development
5.3 Raw Material Suppliers
5.4 Inbound Logistics
5.5 Production
5.6 Marketing
5.7 Outbound Logistics
5.8 Consumers
6. Global Cancer Immunotherapies Market: SWOT Analysis
6.1 Overview
6.2 Strengths
6.3 Weaknesses
6.4 Opportunities
6.5 Threats
7. Global Cancer Immunotherapies Market: Porter’s Five Forces Analysis
7.1 Overview
7.2 Threat of New Entrants
7.3 Threat of Substitutes
7.4 Bargaining Power of Buyers
7.5 Bargaining Power of Suppliers
7.6 Intensity of Rivalry
8. Competitive Landscape
8.1 Market Structure
8.2 Key Players
8.3 Key Success Factors
9. Performance By Region
9.1 North America
9.1.1 Overview
9.1.2 Market Trends
9.1.3 Market Segmentation
9.1.4 Market Forecast
9.2 Europe
9.2.1 Overview
9.2.2 Market Trends
9.2.3 Market Segmentation
9.2.4 Market Forecast
9.3 Asia Pacific
9.3.1 Overview
9.3.2 Market Trends
9.3.3 Market Segmentation
9.3.4 Market Forecast
9.4 Latin America
9.4.1 Overview
9.4.2 Market Trends
9.4.3 Market Segmentation
9.4.4 Market Forecast
9.5 Middle East and Africa
9.5.1 Overview
9.5.2 Market Trends
9.5.3 Market Segmentation
9.5.4 Market Forecast
10 Key Player Profiles
List of Figures
Figure 1: Global: Cancer Immunotherapies Market, 2015 - 2020
Figure 2: Global: Cancer Immunotherapies Market Forecast, 2021 - 2026
Figure 3: Global: Cancer Immunotherapies Market: Price Trends, 2015 - 2020
Figure 4: Global: Cancer Immunotherapies Market Forecast: Price Trends, 2021 - 2026
Figure 5: Global: Cancer Immunotherapies Market: Breakup by Region, 2020
Figure 6: Global: Cancer Immunotherapies Market: Breakup by Type, 2020
Figure 7: Global: Cancer Immunotherapies Market: Breakup by End Use, 2020
Figure 8: Global: Cancer Immunotherapies Industry: Value Chain Analysis
Figure 9: Global: Cancer Immunotherapies Industry: SWOT Analysis
Figure 10: Global: Cancer Immunotherapies Industry: Porter’s Five Forces Analysis
Figure 11: Global: Cancer Immunotherapies Market: Key Players
Figure 12: North America: Cancer Immunotherapies Market, 2015-2020
Figure 13: North America: Cancer Immunotherapies Market: Breakup by Segment, 2020
Figure 14: North America: Cancer Immunotherapies Market Forecast, 2021-2026
Figure 15: Europe: Cancer Immunotherapies Market, 2015-2020
Figure 16: Europe: Cancer Immunotherapies Market: Breakup by Segment, 2020
Figure 17: Europe: Cancer Immunotherapies Market Forecast, 2021-2026
Figure 18: Asia Pacific: Cancer Immunotherapies Market, 2015-2020
Figure 19: Asia Pacific: Cancer Immunotherapies Market: Breakup by Segment, 2020
Figure 20: Asia Pacific: Cancer Immunotherapies Market Forecast, 2021-2026
Figure 21: Latin America: Cancer Immunotherapies Market, 2015-2020
Figure 22: Latin America: Cancer Immunotherapies Market: Breakup by Segment, 2020
Figure 23: Latin America: Cancer Immunotherapies Market Forecast, 2021-2026
Figure 24: Middle East and Africa: Cancer Immunotherapies Market, 2015-2020
Figure 25: Middle East and Africa: Cancer Immunotherapies Market: Breakup by Segment, 2020
Figure 26: Middle East and Africa: Cancer Immunotherapies Market Forecast, 2021-2026
List of Tables
Table 1: Global: Cancer Immunotherapies Industry: Market Summary
Table 2: Global: Cancer Immunotherapies Industry: Market Overview, 2020 and 2026
Table 3: Global: Cancer Immunotherapies Industry: Market Structure
Table 4: Global: Cancer Immunotherapies Market: Market by Region, 2020-2026
Personalize this research
Triangulate with your own data
Get data as per your format and definition
Gain a deeper dive on a specific application, geography, customer or competitor
Any level of personalization
US: +1-213-316-7435
Uk: +44-702-409-7740
sales@syndicatedanalytics.com
The GCC Weight Management Market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. The market is projected to register a CAGR of X% during 2023-2028, reaching US$ XX Billion by 2028.
Read More The GCC orthopedic braces and supports market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe GCC generic drug market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe GCC telemedicine market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe UAE mhealth market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe Saudi Arabia health insurance market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read More+1-213-316-7435
us.sales@syndicatedanalytics.com
+44-702-409-7740
uk.sales@syndicatedanalytics.com
© Copyright Syndicated Analytics 2023.